Changde Yungang Makes Its Debut at CPHI Europe 2024
Release time:
2024-10-22 13:53
From October 8 to 10, the three-day global pharmaceutical exhibition—CPHI Worldwide 2024—came to a successful close in Milan, Italy. The event drew 62,000 attendees from more than 166 countries and regions and featured over 2,400 exhibitors, igniting a wave of excitement at the industry’s annual flagship gathering and fully unleashing boundless business dynamism and untapped industry potential. Changde Yungang made a prominent appearance at the show, garnering widespread attention for its extensive portfolio of bile-related products and cutting-edge innovation capabilities.
During the exhibition, Changde Yungang engaged in in-depth exchanges with industry experts, partners, and customers from around the world, sharing the company’s latest achievements and future development plans, which were unanimously recognized and highly praised by clients.
The three-day CPHI Europe exhibition not only deepened the Changde Yungang business team’s understanding of the current state of the industry but also advanced the company’s overseas marketing efforts and its internationalization strategy. The event further enhanced Changde Yungang’s global and professional image, providing valuable opportunities to establish new business connections and strengthen existing partnerships. As a result, the company has further solidified its position in the global pharmaceutical market and laid a robust foundation for future growth.
World Pharmaceutical Active Pharmaceutical Ingredient Exhibition,CPHI Europe Exhibition,Bile-related Resource Product Line,Pharmaceutical Exhibition
The 94th China International API, Intermediates, Packaging and Equipment Exhibition (API China) will be held at the Shanghai National Exhibition and Convention Center, in conjunction with the 92nd National Pharmaceutical Trade Fair and the 2026 China International Health & Nutrition Expo, all taking place at the same venue and during the same period.
The 2026 China Feed Industry Exhibition will be held from April 18 to 20 at the Nanchang Greenland International Expo Center. Yungang Bio— a national high-tech enterprise specializing in bile acids—cordially invites you to visit Booth B3E193. The company will showcase three key strengths: more than 20 patented inventions in the fields of biopharmaceuticals and animal health, underscoring its patent leadership; a 1,500-square-meter R&D center supported by a team of nearly 60 experts, ensuring robust R&D capabilities; and active participation in the development of national standards coupled with a 10,000-ton-scale smart production line, guaranteeing reliable supply. With a steadfast focus on innovation in bile acids, we look forward to “making waves” together in Nanchang and exploring collaborative opportunities for the future!
From November 12 to 14, 2025, Changde Yungang Bio will make its debut at the API China Chongqing exhibition, showcasing a comprehensive portfolio of bile-related products, including bilirubin, chenodeoxycholic acid, ursodeoxycholic acid, bile salts, and bile acid feed additives. During the event, the company engaged in in-depth exchanges with industry peers on technological trends and market demands, expanded its network of collaborative partners, and received an enthusiastic response from attendees. Looking ahead, Yungang Bio will continue to deepen its expertise in the bile resource sector, delivering higher-quality products and services to customers and working together to create new value for the industry.
Next Page
Company address: No.8 fenglin road, Sujiadu Community, Zhangmuqiao Street, Changde Economic and Technological Development Zone, Hunan Province